Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BioVeras
AddedFeb 17, 2024
UpdatedJun 18, 2026
BioVeras

BioVeras

Pre-Seed

BioVeras: A Life Science Blockchain firm innovating AI-driven clinical decision support software.

HQ
Wayne, PA, US
Founded
2020
Overview
Compare
Fundraising
Employees

BioVeras is a life science blockchain company focused on innovating AI-driven clinical decision support software. Their mission is to enhance healthcare outcomes through advanced artificial intelligence and machine learning technologies. BioVeras aims to provide cutting-edge solutions for healthcare professionals, improving the accuracy and efficiency of clinical decisions.

BioVeras has made significant strides in integrating blockchain technology with AI to ensure secure and reliable healthcare data management. Their solutions have gained attention for their potential to transform clinical practices. BioVeras continues to impact the healthcare industry by driving technological advancements and fostering trust in digital health innovations.

BioVeras - Similar Companies

Visionairy Health logo

Visionairy Health

Verasana logo

Verasana

verasana.com

Verisim Life logo

Verisim Life

verisimlife.com

CytoVeris logo

CytoVeris

cytoveris.com

Biogenesis Trials logo

Biogenesis Trials

mybiogenesis.com

BioAI Health logo

BioAI Health

bioaihealth.com

Biosim logo

Biosim

Aiva logo

Aiva

aiva.ai

Verilink logo

Verilink

Mdverse logo

Mdverse

mdverse.io

Regenerative Bio logo

Regenerative Bio

regen-bio.us

Veriken logo

Veriken

veriken.com

theVinci.ai logo

theVinci.ai

thevinci.ai

VeraMorph logo

VeraMorph

veramorph.com

Regard logo

Regard

withregard.com

BioVeras - Quick Facts

Who are BioVeras' competitors?

Companies similar to BioVeras include Visionairy Health, Verasana, Verisim Life and CytoVeris.

When was BioVeras founded?

BioVeras was founded in 2020.

Where is BioVeras' headquarters located?

BioVeras' headquarters is located in Wayne, PA, US.

When was BioVeras' last funding round?

BioVeras' most recent funding round was for $25k (USD) in July 2022.

How much has BioVeras raised to-date?

As of Jul 14, 2022, BioVeras has raised a total of $25k (USD).

How many employees does BioVeras have?

BioVeras has 5 employees as of Feb 4, 2024.

BioVeras - Classification

Ownership
  • Private
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Software
Tags
  • Blockchain
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software